Baseline predictors of cognitive decline in patients with cerebral small vessel disease

Journal of Alzheimer's Disease

Volumn 42, Issue , 2014, Pages S37-S43

  Pavlovic, Aleksandra M ^a   Pekmezovic, Tatjana ^a   Tomic, Gordana ^a   Trajkovic, Jasna Zidverc ^a   Sternic, Nada ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Lacunar infarct; small vessel disease; stroke; vascular cognitive impairment; white matter hyperintensities

Indexed keywords

ADULT; AGE RELATED WHITE MATTER CHANGES SCALE; ASSESSMENT OF HUMANS; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; CONFERENCE PAPER; FAZEKAS SCALE; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HUMAN; LACUNAR STROKE; MAJOR CLINICAL STUDY; MALE; MENTAL DETERIORATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; RANKIN SCALE; RISK FACTOR; WHITE MATTER; AGED; ANALYSIS OF VARIANCE; BRAIN; COGNITION DISORDERS; COMPLICATION; LONGITUDINAL STUDY; MENTAL HEALTH; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SURVIVAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRAIN; BRAIN INFARCTION; CEREBRAL SMALL VESSEL DISEASES; COGNITION DISORDERS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; WHITE MATTER;

EID: 84920573673     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-132606     Document Type: Conference Paper

References (49)

1. de LaatKF,TuladharAM,van NordenAG, Norris DG, Zwiers MP, de Leeuw FE (2011) Loss of white matter integrity is associated with gait disorders in cerebral small vessel disease. Brain 134(Pt 1), 73-83.
2. Jokinen H, Kalska H, Ylikoski R, Madureira S, Verdelho A, Gouw A, Scheltens P, Barkhof F, Visser MC, Fazekas F, Schmidt R, O'Brien J, Hennerici M, Baezner H, Waldemar G, Wallin A, Chabriat H, Pantoni L, Inzitari D, Erkinjuntti T; LADIS group (2009) MRI-defined subcortical ischemic vascular disease: Baseline clinical and neuropsychological findings. The LADIS Study. Cerebrovasc Dis 27, 336-344.
3. Pantoni L (2010) Cerebral small vessel disease: From pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 9, 689-701.
4. Teodorczuk A, Firbank MJ, Pantoni L, Poggesi A, Erkinjuntti T,Wallin A,Wahlund LO, Scheltens P,Waldemar G, Schrotter G, Ferro JM, Chabriat H, Bazner H, Visser M, Inzitari D, O'Brien JT, Group LADIS (2010) Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study. Psychol Med 40, 603-610.
5. Cordonnier C, van der Flier WM, Sluimer JD, Leys D, Barkhof F, Scheltens P (2006) Prevalence and severity of microbleeds in a memory clinic setting. Neurology 66, 1356-1360.
6. Kloppenborg RP, Nederkoorn PJ, Grool AM, Vincken KL, MaliWP,Vermeulen M, van der GraafY, Geerlings MI, Study SMART, Group (2012) Cerebral small-vessel disease and progression of brain atrophy: The SMART-MR study. Neurology 79, 2029-2036.
7. Verdelho A, Madureira S, Moleiro C, Ferro JM, Santos CO, Erkinjuntti T, Pantoni L, Fazekas F, Visser M, Waldemar G, Wallin A, HennericiM,Inzitari D, StudyLADIS(2010) White matter changes and diabetes predict cognitive decline in the elderly: The LADIS study. Neurology 75, 160-167.
8. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O'Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, de Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S, HachinskiV, Kilimann I,MokV, Oostenbrugge Rv, Pantoni L, Speck O, Stephan BC, Teipel S, Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving B, Gorelick PB, Dichgans M; STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1) (2013) Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 12, 822-838.
9. Jokinen H, Lipsanen J, Schmidt R, Fazekas F, Gouw AA, van der FlierWM,Barkhof F, Madureira S,Verdelho A, Ferro JM, Wallin A, Pantoni L, Inzitari D, Erkinjuntti T; LADIS Study Group (2012) Brain atrophy accelerates cognitive decline in cerebral small vessel disease: The LADIS study. Neurology 78, 1785-1792.
10. The LADIS Study Group, Poggesi A, Pantoni L, Inzitari D, Fazekas F, Ferro J, O'Brien J, Hennerici M, Scheltens P, Erkinjuntti T, Visser M, Langhorne P, Chabriat H, Waldemar G, Wallin A, Wahlund A (2011) 2001-2011: A decade of the LADIS (Leukoaraiosis And DISability) study: What have we learned about white matter changes and small-vessel disease? Cerebrovasc Dis 32, 577-588.
11. Verdelho A, Madureira S, Moleiro C, Ferro JM, O'Brien JT, Poggesi A, Pantoni L, Fazekas F, Scheltens P, Waldemar G, Wallin A, Erkinjuntti T, Inzitari D, Study LADIS (2013) Depressive symptoms predict cognitive decline and dementia in older people independently of cerebral white matter changes: The LADIS study. J Neurol Neurosurg Psychiatry 84, 1250-1254.
12. Lawrence AJ, Patel B, Morris RG, MacKinnon AD, Rich PM, Barrick TR, Markus HS (2013) Mechanisms of cognitive impairment in cerebral small vessel disease: Multimodal MRI results from the St George's cognition and neuroimaging in stroke (SCANS) study. PLoS One 22, e61014.
13. Zhou A, Jia J (2009) Different cognitive profiles between mild cognitive impairment due to cerebral small vessel disease and mild cognitive impairment of Alzheimer's disease origin. J Int Neuropsychol Soc 15, 898-905.
14. O'SullivanM, Jones DK, Summers PE, Morris RG,Williams SC, Markus HS (2001) Evidence for cortical "disconnection" as a mechanism of age-related cognitive decline. Neurology 57, 632-638.
15. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM (2003) Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 348, 1215-1222.
16. De Groot JC, De Leeuw FE, Oudkerk M, Van Gijn J, Hofman A, Jolles J, BretelerMM(2002) Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol 52, 335-341.
17. Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Jolles J, Koudstaal PJ, Hofman A, Breteler MM (2005). Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 128(Pt 9), 2034-2041.
18. Garde E, Lykke Mortensen E, Rostrup E, Paulson OB (2005) Decline in intelligence is associated with progression in white matter hyperintensity volume. J Neurol Neurosurg Psychiatry 76, 1289-1291.
19. Kramer JH, Mungas D, Reed BR, Wetzel ME, Burnett MM, Miller BL, Weiner MW, Chui HC (2007) Longitudinal MRI and cognitive change in healthy elderly. Neuropsychology 21, 412-418.
20. van der Flier WM, van Straaten EC, Barkhof F, Verdelho A, Madureira S, Pantoni L, Inzitari D, Erkinjuntti T, Crisby M, Waldemar G, Schmidt R, Fazekas F, Scheltens P (2005) Small vessel disease and general cognitive function in nondisabled elderly: The LADIS study. Stroke 36, 2116-2120.
21. Jokinen H, Gouw AA, Madureira S, Ylikoski R, van Straaten EC, van der Flier WM, Barkhof F, Scheltens P, Fazekas F, Schmidt R, Verdelho A, Ferro JM, Pantoni L, Inzitari D, Erkinjuntti T, Study LADIS, Group (2011) Incident lacunes influence cognitive decline: The LADIS study. Neurology 76, 1872-1878.
22. Pantoni L, BasileAM,Pracucci G, Asplund K, Bogousslavsky J, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Hennerici M, O'brien J, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Inzitari D (2005) Impact of age-related cerebral white matter changes on the transition to disability-the LADIS study: Rationale, design and methodology. Neuroepidemiology 24, 51-62.
23. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE III. Classification of subtype of acute ischemic stroke (1993) Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24, 35-41.
24. Folstein MF, Folstein SE, McHugh PR (1975) Mini-Mental State. J Psychiatr Res 12, 189-198.
25. Lezak MD (2004) Neuropsychological assessment, Oxford University Press, New York.
26. Heaton RK (1981) A manual for the Wisconsin Card Sorting Test. Psychological Assessment Resources Inc., Odessa, FL.
27. Osterrieth PA (1944) Le test de copie d'une figure complex: Contribution È l'A° tude de la perception de la mA° moire. Arch Psychologie 30, 286-356.
28. ReyA(1964) L'examen clinique en psychologie, Presses Universitaires de France, Paris.
29. Kaplan EF, Goodglass H, Weintraub S (1978) The Boston Naming Test. Boston.
30. Goodglass H, Kaplan E (1983) The assessment of aphasia and related disorders. Lea & Febiger, Philadelphia.
31. Hachinski VC, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, Powers WJ, DeCarli C, Merino JG, Kalaria RN, Vinters HV, Holtzman DM, Rosenberg GA, Wallin A, Dichgans M, Marler JR, Leblanc GG (2006) National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards. Stroke 37, 2220-2241.
32. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, et al. (1993) Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43, 250-260.
33. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edition. American Psychiatric Association, Washington, DC.
34. Wahlund L, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjogren M, Wallin A, Ader H, Leys D, Pantoni L, Pasquier F, Erkinjuntti T, Scheltens P; European Task Force on Age-Related White Matter Changes (2001) A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32, 1318-1322.
35. Fazekas F, Barkhol F,Wahlund L-O, Pantoni L, Erkinjuntti T, Scheltens P, Schmidt R (2002) CT and MRI rating of white matter lesions. Cerebrovasc Dis 13(suppl 2), 31-36.
36. Gouw AA1, van der Flier WM, Fazekas F, van Straaten EC, Pantoni L, Poggesi A, Inzitari D, Erkinjuntti T, Wahlund LO, Waldemar G, Schmidt R, Scheltens P, Barkhof F, Study LADIS, Group (2008) Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: The Leukoaraiosis and Disability study. Stroke 39, 1414-1420.
37. WardlawJM1, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O'Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, de Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S, HachinskiV, Kilimann I,MokV, Oostenbrugge Rv, Pantoni L, Speck O, Stephan BC, Teipel S, Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving B, Gorelick PB, Dichgans M; STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1)(2013) Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 12, 822-838.
38. Madureira S, Verdelho A, Moleiro C, Ferro JM, Erkinjuntti T, Jokinen H, Pantoni L, Fazekas F, Van der Flier W, Visser M, Waldemar G, Wallin A, Hennerici M, Inzitari D (2010) Neuropsychological predictors of dementia in a three-year follow-up period: Data from the LADIS study. Dement Geriatr Cogn Disord 29, 325-334.
39. Tullberg M, Fletcher E, DeCarli C, Mungas D, Reed BR, Harvey DJ, Weiner MW, Chui HC, Jagust WJ (2004) White matter lesions impair frontal lobe function regardless of their location. Neurology 63, 246-253.
40. Inzitari D, Simoni M, Pracucci G, Poggesi A, Basile AM, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Hennerici M, Langhorne P, O'Brien J, Barkhof F, Visser MC, Wahlund LO, Waldemar G, Wallin A, Pantoni L; LADIS Study Group (2007) Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: The LADIS study. Arch Intern Med 167, 81-88.
41. Pantoni L, Poggesi A, Basile AM, Pracucci G, Barkhof F, Chabriat H, Erkinjuntti T, Ferro JM, Hennerici M, O'Brien J, Schmidt R, Visser MC, Wahlund LO, Waldemar G, Wallin A, Inzitari D; LADIS Study Group (2006) Leukoaraiosis predicts hidden global functioning impairment in nondisabled older people: The LADIS (Leukoaraiosis and Disability in the Elderly) Study. J Am Geriatr Soc 54, 1095-1101.
42. Makin SD, Turpin S, Dennis MS, Wardlaw JM (2013) Cognitive impairment after lacunar stroke: Systematic review and meta-analysis of incidence, prevalence and comparison with other stroke subtypes. J Neurol Neurosurg Psychiatry 84, 893-900.
43. Schmidt R, Petrovic K, Ropele S, Enzinger C, Fazekas F (2007) Progression of leukoaraiosis and cognition. Stroke 38, 2619-2625.
44. Schmidt R, Berghold A, Jokinen H, Gouw AA, van der Flier WM, Barkhof F, Scheltens P, Petrovic K, Madureira S, Verdelho A, Ferro JM, Waldemar G, Wallin A, Wahlund LO, Poggesi A, Pantoni L, Inzitari D, Fazekas F, Erkinjuntti T, Study LADIS, Group (2012) White matter lesion progression in LADIS: Frequency, clinical effects, and sample size calculations. Stroke 43, 2643-2647.
45. Zhang M, Chen M,Wang Q, YunW, Zhang Z, Yin Q, Huang Q, ZhuW(2013) Relationship between cerebral microbleeds and cognitive function in lacunar infarct. J Int Med Res 41, 347-355.
46. Lei C, Lin S, TaoW, Hao Z, Liu M,Wu B (2013) Association between cerebral microbleeds and cognitive function: A systematic review. J Neurol Neurosurg Psychiatry 84, 693-697.
47. Topakian R, Barrick TR, Howe FA,Markus HS (2010) Bloodbrain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis. J Neurol Neurosurg Psychiatry 81, 192-197.
48. van Norden AG, van Uden IW, de Laat KF, van Dijk EJ, de Leeuw FE (2012) Cognitive function in small vessel disease: The additional value of diffusion tensor imaging to conventional magnetic resonance imaging: The RUN DMC study. J Alzheimers Dis 32, 667-676.
49. Papma JM, de Groot M, de Koning I, Mattace-Raso FU, van der Lugt A,VernooijMW, Niessen WJ, van Swieten JC,Koudstaal PJ, Prins ND, Smits M (2014) Cerebral small vessel disease affects white matter microstructure in mild cognitive impairment. Hum Brain Mapp 35, 2836-2851.